(Q54579499)

1 June 2018

title

Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells. (English)

1 reference

1 June 2018

3

Daniel Levesque

1 reference

1 June 2018

author name string

Keith Chiasson

series ordinal

1

1 reference

1 June 2018

Benoît Daoust

series ordinal

2

1 reference

1 June 2018

Maria-Grazia Martinoli

series ordinal

4

1 reference

1 June 2018

publication date

1 August 2006

1 reference

1 June 2018

published in

Neurotoxicity Research

1 reference

1 June 2018

volume

10

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

31-42

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/bf03033332

exact match

0 references

cites work

A review of neuroprotective agents

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03033332

Neuroprotection and dopamine agonists

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03033332

Neuroprotection in PD—A role for dopamine agonists?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03033332

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

21 January 2018

1 reference

12 December 2020

Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions

1 reference

12 December 2020

G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells

1 reference

12 December 2020

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity

1 reference

12 December 2020

Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats

1 reference

12 December 2020

Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons.

1 reference

12 December 2020

Expression of dopamine transporter at the tips of growing neurites of PC12 cells

1 reference

12 December 2020

Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms

1 reference

12 December 2020

A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide

1 reference

12 December 2020

The histological effects of intracerebral injection or infusion of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and MPP+ (1-methyl-4-phenylpyridinium) in rat and mouse.

1 reference

12 December 2020

Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes.

1 reference

12 December 2020

Cloning and expression of a rat D2 dopamine receptor cDNA

1 reference

12 December 2020

Estrogen and the brain: beyond ER-alpha and ER-beta

1 reference

12 December 2020

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor

1 reference

12 December 2020

Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress

1 reference

12 December 2020

1 reference

12 December 2020

Oxidative mechanisms in nigral cell death in Parkinson's disease.

1 reference

12 December 2020

Effects of estradiol, phytoestrogens, and Ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress

1 reference

12 December 2020

MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters

1 reference

12 December 2020

From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens.

1 reference

12 December 2020

Measurement of lymphocyte cytotoxicity by assessing endogenous alkaline phosphatase activity of the target cells

1 reference

12 December 2020

Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors

1 reference

12 December 2020

Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.

1 reference

12 December 2020

Modulation of prolactin expression by xenoestrogens

1 reference

12 December 2020

Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases

1 reference

12 December 2020

An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.

1 reference

12 December 2020

Peculiarities of L: -DOPA treatment of Parkinson's disease

1 reference

12 December 2020

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist

1 reference

12 December 2020

Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

1 reference

12 December 2020

Psychosis: impact on the patient and family

1 reference

12 December 2020

Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil

1 reference

12 December 2020

Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures

1 reference

12 December 2020

Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity

1 reference

12 December 2020

Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.

1 reference

12 December 2020

Diagnostic and therapeutic value of apomorphine in Parkinsonian patients

1 reference

12 December 2020

Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride].

1 reference

12 December 2020

Bromocriptine and clozapine regulate dopamine 2 receptor gene expression in the mouse striatum

1 reference

12 December 2020

D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo.

1 reference

12 December 2020

Are dopamine receptor agonists neuroprotective in Parkinson's disease?

1 reference

12 December 2020

Ropinirole: current status of the studies

1 reference

12 December 2020

Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells

1 reference

12 December 2020

Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.

1 reference

12 December 2020

Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain?

1 reference

12 December 2020

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.

1 reference

12 December 2020

Dopamine receptor signaling

1 reference

12 December 2020

Acid phosphatase: endpoint for in vitro toxicity tests

1 reference

12 December 2020

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

1 reference

12 December 2020

7-OH-DPAT-induced inhibition of norepinephrine release in PC12 cells

1 reference

12 December 2020

D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells.

1 reference

12 December 2020

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor

1 reference

12 December 2020

Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table

1 reference

12 December 2020

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

12 December 2020

Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells

1 reference

12 December 2020

The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers

1 reference

12 December 2020

Characterization and time course of MPP+ -induced apoptosis in human SH-SY5Y neuroblastoma cells

1 reference

12 December 2020

D2-protein in PC12 pheochromocytoma cells after nerve growth factor stimulation

1 reference

12 December 2020

Tolerance to peripheral, but not central, effects of ropinirole, a selective dopamine D2-like receptor agonist

1 reference

12 December 2020

Mechanisms of MPP(+) incorporation into cerebellar granule cells

1 reference

12 December 2020

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

1 reference

12 December 2020

Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection

1 reference

12 December 2020

Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland

1 reference

12 December 2020

Effect of sesaminol glucosides on beta-amyloid-induced PC12 cell death through antioxidant mechanisms

1 reference

12 December 2020

Apomorphine protects against MPTP-induced neurotoxicity in mice

1 reference

12 December 2020

Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity

1 reference

12 December 2020

Dopamine agonists: the treatment for Parkinson's disease in the XXI century?

1 reference

12 December 2020

Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.

1 reference

12 December 2020

Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection.

1 reference

12 December 2020

D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins

1 reference

12 December 2020

Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage

1 reference

12 December 2020

Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR.

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

Neurotoxins and neurotoxic species implicated in neurodegeneration.

1 reference

12 December 2020

1-Methyl-4-phenylpyridinium (MPP+)-induced cell death in PC12 cells: inhibitory effects of several drugs

1 reference

12 December 2020

Involvement of free radicals in MPP+ neurotoxicity against rat dopaminergic neurons in culture

1 reference

12 December 2020

Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.

1 reference

12 December 2020

Role of the D2 dopamine receptor in molecular adaptation to chronic hypoxia in PC12 cells

1 reference

12 December 2020

Do dopamine agonists provide neuroprotection?

1 reference

12 December 2020

Nerve growth factor and fibroblast growth factor regulate neurite outgrowth and gene expression in PC12 cells via both protein kinase C- and cAMP-independent mechanisms

1 reference

12 December 2020

Combined effect of xenoestrogens and growth factors in two estrogen-responsive cell lines

1 reference

12 December 2020

Is there neuroprotection in Parkinson syndrome?

1 reference

12 December 2020

Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.

1 reference

12 December 2020

The Pivotal Role of Iron in NF-kappaB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033332

1 reference

1 June 2018

1 reference

1 June 2018